Review



spike b cell analysis kit  (Miltenyi Biotec)


Bioz Verified Symbol Miltenyi Biotec is a verified supplier
Bioz Manufacturer Symbol Miltenyi Biotec manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 97

    Structured Review

    Miltenyi Biotec spike b cell analysis kit
    Spike B Cell Analysis Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 13 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sars-cov/SARS-CoV-2+Spike+B+Cell+Analysis+Kit%2C+anti-human/pmc09295666__jitc___2022___004953supp002-38-14-19
    Average 97 stars, based on 13 article reviews
    spike b cell analysis kit - by Bioz Stars, 2026-09
    97/100 stars

    Images

    Related Articles

    Cell Analysis:

    Article Title: Analysis of humoral and cellular immune activation up to 21 months after heterologous and homologous COVID-19 vaccination
    Article Snippet: .. The analysis of SARS-CoV-2-specific B-cells was performed using the SARS-CoV-2 Spike B Cell Analysis Kit, anti-human (Miltenyi Biotec). ..

    Article Title: Impact of chemotherapy on humoral and cellular immune responses to COVID-19 vaccination in patients with solid tumors
    Article Snippet: .. Spike-specific memory B cells were detected by SARS-CoV-2 spike B cell Analysis kit (Miltenyi Biotec cat. no. 130-128-022), according to manufacturer’s instructions. ..

    Article Title: Longitudinal Evaluation of Humoral and Cellular Immunity After BNT162b2 COVID-19 Vaccination: Influence of Booster Type, Infection and Chronic Health Conditions.
    Article Snippet: .. The SARS-CoV-2 Spike B Cell Analysis Kit was used to analyzespecific Spike antibodies expressed by human B-cells (Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach; Germany). ..

    Article Title: Longitudinal Evaluation of Humoral and Cellular Immunity After BNT162b2 COVID-19 Vaccination: Influence of Booster Type, Infection and Chronic Health Conditions
    Article Snippet: .. The SARS-CoV-2 Spike B Cell Analysis Kit was used to analyzespecific Spike antibodies expressed by human B-cells (Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach; Germany). ..

    Article Title: Analysis of humoral and cellular immune activation up to 21 months after heterologous and homologous COVID-19 vaccination.
    Article Snippet: .. 2.5 Quantification of SARS-CoV-2 specific B-cells The analysis of SARS-CoV-2-specific B-cells was performed using the SARS-CoV-2 Spike B Cell Analysis Kit, anti-human (Miltenyi Biotec). ..

    Article Title: GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial.
    Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Mouse anti human CD19 conjugated to APC-Vio770 (clone LT19) Miltenyi Biotec Cat# 130-113-166; RRID: AB_2725994 mouse anti human CD27 conjugated to Vio Bright FITC (clone M-T271) Miltenyi Biotec Cat# 130-113-634; RRID: AB_2751160 mouse anti human IgA conjugated to VioGreen (clone IS11-8E10) Miltenyi Biotec Cat# 130-113-481; RRID: AB_2734099 mouse anti human IgM conjugated to APC (clone Pj2-22H3) Miltenyi Biotec Cat# 130-122-915; RRID: AB_2801965 mouse anti human IgG conjugated to VioBlue (clone IS11-3B2.2.3) Miltenyi Biotec Cat# 130-119-881; RRID: AB_2751904 mouse anti human CD24 conjugated to BV711 (clone ML5) BD Biosciences Cat# 563401; RRID: AB_2631261 mouse anti human CD107a conjugated to PE-CF594 (clone H4A3) BD Biosciences Cat# 562628; RRID: AB_2737686 mouse anti human CD3 conjugated to BUV395 (clone UCHT1) BD Biosciences Cat# 563546; RRID: AB_2744387 mouse anti human CD4 conjugated to BUV737 clone SK3 BD Biosciences Cat# 612748; RRID: AB_2870079 mouse anti human CD8 conjugated to BV605 (clone SK1) BD Biosciences Cat# 564116; RRID: AB_2869551 mouse anti human CD154 conjugated to BB700 (clone TRAP1) BD Biosciences Cat# 745814; RRID: AB_2743265 mouse anti human IFNg conjugated to APC clone B27 BD Biosciences Cat# 554702; RRID: AB_398580 rat anti human IL-2 conjugated to PE (clone mQ1-17H12) BD Biosciences Cat# 559334; RRID: AB_397231 mouse anti human TNFa conjugated to BV650 (clone Mab11) BD Biosciences Cat# 563418; RRID: AB_2738194 mouse anti human CD69 conjugated to APC-R700 (clone FN50) BD Biosciences Cat# 565154; RRID: AB_2744449 Biological samples Human Serum Study Participants N/A Human PBMC Study Participants N/A Chemicals, peptides, and recombinant proteins PepMixTM SARS-CoV-2 (Spike Glycoprotein) JPT Cat# PM-WCPV-S-1 PepMixTM SARS-CoV-2 (Spike B.1.617.2/ Delta) JPT Cat# PM-SARS2-SMUT06-1 PepMixTM SARS-CoV-2 (Spike B.1.1.529/ BA.1/Omicron) JPT Cat# PM-SARS2-SMUT08-1 CEFX Ultra SuperStim Pool JPT Cat# PM-CEFX-1 Overlapping SARS-CoV-2 Spike 15mers custom ordered from Elabscience Biotech Inc (Lanini S. et al., SciTraslMed 2021) N/A, Staphylococcal enterotoxin B from Staphylococcus aureus Sigma-Aldrich Cat# S4881 GolgiPlug BD Biosciences Cat# 555029 (Continued on next page) e1 Cell Reports Medicine 4, 101084, June 20, 2023 .. REAGENT or RESOURCE SOURCE IDENTIFIER Brilliant Stain Buffer BD Biosciences Cat# 563794 BD Fixation/Permeabilization Kit BD Biosciences Cat# 554714 FVS780 BD Biosciences Cat# 565388 HyClone Defined FBS, US Origin, 500 mL Cytiva Cat# SH30070.03 CTL-WashTM Supplement 10x Immunospot Cat# CTLW-010 CellTrace Violet ThermoFisher Cat# C34571 Critical commercial assays COVID-SeroIndex, Kantaro Quantitative SARS-CoV-2 IgG Antibody Kit (Spike) R&D Systems Cat# DSR200 ARCHITECT SARS-CoV-2 IgG kit (Nucleocapsid) Abbot Cat# 6R86 ARCHITECT SARS-CoV-2 IgG II Quant (RBD) Abbot Cat# 6S60 Human IFN-g ELISpot plus kit Mabtech Cat# 3420-4APT IFNg-IL5 Fluorospot Mabtech Cat# FSP-0108 SARS-CoV-2 Spike B cell analysis kit Miltenyi Biotec Cat# 130-128-022 SARS-CoV-2 live neutralization assay Viroclinics Biosciences-Cerba N/A Pseudo-neutralization assay (D614 and D strains) Nexelis-Q2 solutions https://nexelis.com/our-expertise/ infectious-diseases/covid-19/ Pseudo-neutralization assay (D614) Monogram Biosciences-Labcorp https://monogrambio.labcorp.com/ phenosense-sars-cov-2neutralizing-antibody Software and algorithms Graphpad PRISM 7 GraphPad RRID:SCR_002798 FlowJo 10 BD Biosciences RRID:SCR_008520 SAS System software 9.4 SAS Institute Inc. RRID:SCR_008567 CTL Immunospot suite 2.7 Cellular Technology Limited RRID:SCR_011082 SPICE 6 NIH/NIAID https://niaid.github.io/spice/ RRID:SCR_016603 Article ll OPEN ACCESS .. Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, Stefania Capone (Stefania.capone@reithera.com).

    Recombinase Polymerase Amplification:

    Article Title: Biopsy-proven immune-mediated hepatitis after valoctocogene roxaparvovec.
    Article Snippet: .. Antibody target (eventual alias in brackets) Fluorochrome Clone Company Catalog # CD127 BB700 HIL-7R-M21 BD 566398 CD137 (41BB) BUV615 4B4-1 LIGAND BD 751492 CD183 (CXCR3) PECY7 1C6/CXCR3 BD 560831 CD185 (CXCR5) APC-CY7 J252D4 BioLegend 356926 CD19 APC-Vio 770 LT19 Miltenyi 130-128- 022 CD195 (CCR5) FITC HEK/1/85a BioLegend 313705 CD196 (CCR6) APCR700 11A9 BD 565173 CD197 (CCR7) BV711 150503 BD 566602 CD21 PECY5 B-ly4 BD 551064 CD138 Pe-CF594 MI15 BD 564606 CD25 Pecy5 M-A251 BD 555433 CD27 BUV737 L128 BD 564301 CD27 Vio Bright FITC M-T271 Miltenyi 130-128- 022 CD279 (PD1) BV650 EH12.1 BD 564104 CD3 BUV 805 UCHT1 BD 612895 CD4 BUV 395 SK3 BD 563550 CD4 BUV737 SK3 BD 612748 CD40L PECY5 cl.24-31 BioLegend 310808 CD45RA BUV496 HI100 BD 750258 CD45RO BV605 UCHL1 BD 562791 CD69 BV650 FN50 BD 563835 CD8 BUV 563 RPA-T8 BD 612914 FOXP3 PE-CF594 259D/C7 BD 562421 GRANZYME B BV421 GB 11 BD 563389 GRANZYME K Alexa Fluor647 G3H69 BD 566655 IgD BV480 IA6-2 BD 566138 IgG VioBlue IS113B2.2.3 Miltenyi 130-128- 022 IgM APC PJ2-22H3 Miltenyi 130-128- 022 LIVE AND DEAD FIX VIAB 780 - BD 565388 LIVE AND DEAD Aqua - thermofisher L34957 ..

    Staining:

    Article Title: GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial.
    Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Mouse anti human CD19 conjugated to APC-Vio770 (clone LT19) Miltenyi Biotec Cat# 130-113-166; RRID: AB_2725994 mouse anti human CD27 conjugated to Vio Bright FITC (clone M-T271) Miltenyi Biotec Cat# 130-113-634; RRID: AB_2751160 mouse anti human IgA conjugated to VioGreen (clone IS11-8E10) Miltenyi Biotec Cat# 130-113-481; RRID: AB_2734099 mouse anti human IgM conjugated to APC (clone Pj2-22H3) Miltenyi Biotec Cat# 130-122-915; RRID: AB_2801965 mouse anti human IgG conjugated to VioBlue (clone IS11-3B2.2.3) Miltenyi Biotec Cat# 130-119-881; RRID: AB_2751904 mouse anti human CD24 conjugated to BV711 (clone ML5) BD Biosciences Cat# 563401; RRID: AB_2631261 mouse anti human CD107a conjugated to PE-CF594 (clone H4A3) BD Biosciences Cat# 562628; RRID: AB_2737686 mouse anti human CD3 conjugated to BUV395 (clone UCHT1) BD Biosciences Cat# 563546; RRID: AB_2744387 mouse anti human CD4 conjugated to BUV737 clone SK3 BD Biosciences Cat# 612748; RRID: AB_2870079 mouse anti human CD8 conjugated to BV605 (clone SK1) BD Biosciences Cat# 564116; RRID: AB_2869551 mouse anti human CD154 conjugated to BB700 (clone TRAP1) BD Biosciences Cat# 745814; RRID: AB_2743265 mouse anti human IFNg conjugated to APC clone B27 BD Biosciences Cat# 554702; RRID: AB_398580 rat anti human IL-2 conjugated to PE (clone mQ1-17H12) BD Biosciences Cat# 559334; RRID: AB_397231 mouse anti human TNFa conjugated to BV650 (clone Mab11) BD Biosciences Cat# 563418; RRID: AB_2738194 mouse anti human CD69 conjugated to APC-R700 (clone FN50) BD Biosciences Cat# 565154; RRID: AB_2744449 Biological samples Human Serum Study Participants N/A Human PBMC Study Participants N/A Chemicals, peptides, and recombinant proteins PepMixTM SARS-CoV-2 (Spike Glycoprotein) JPT Cat# PM-WCPV-S-1 PepMixTM SARS-CoV-2 (Spike B.1.617.2/ Delta) JPT Cat# PM-SARS2-SMUT06-1 PepMixTM SARS-CoV-2 (Spike B.1.1.529/ BA.1/Omicron) JPT Cat# PM-SARS2-SMUT08-1 CEFX Ultra SuperStim Pool JPT Cat# PM-CEFX-1 Overlapping SARS-CoV-2 Spike 15mers custom ordered from Elabscience Biotech Inc (Lanini S. et al., SciTraslMed 2021) N/A, Staphylococcal enterotoxin B from Staphylococcus aureus Sigma-Aldrich Cat# S4881 GolgiPlug BD Biosciences Cat# 555029 (Continued on next page) e1 Cell Reports Medicine 4, 101084, June 20, 2023 .. REAGENT or RESOURCE SOURCE IDENTIFIER Brilliant Stain Buffer BD Biosciences Cat# 563794 BD Fixation/Permeabilization Kit BD Biosciences Cat# 554714 FVS780 BD Biosciences Cat# 565388 HyClone Defined FBS, US Origin, 500 mL Cytiva Cat# SH30070.03 CTL-WashTM Supplement 10x Immunospot Cat# CTLW-010 CellTrace Violet ThermoFisher Cat# C34571 Critical commercial assays COVID-SeroIndex, Kantaro Quantitative SARS-CoV-2 IgG Antibody Kit (Spike) R&D Systems Cat# DSR200 ARCHITECT SARS-CoV-2 IgG kit (Nucleocapsid) Abbot Cat# 6R86 ARCHITECT SARS-CoV-2 IgG II Quant (RBD) Abbot Cat# 6S60 Human IFN-g ELISpot plus kit Mabtech Cat# 3420-4APT IFNg-IL5 Fluorospot Mabtech Cat# FSP-0108 SARS-CoV-2 Spike B cell analysis kit Miltenyi Biotec Cat# 130-128-022 SARS-CoV-2 live neutralization assay Viroclinics Biosciences-Cerba N/A Pseudo-neutralization assay (D614 and D strains) Nexelis-Q2 solutions https://nexelis.com/our-expertise/ infectious-diseases/covid-19/ Pseudo-neutralization assay (D614) Monogram Biosciences-Labcorp https://monogrambio.labcorp.com/ phenosense-sars-cov-2neutralizing-antibody Software and algorithms Graphpad PRISM 7 GraphPad RRID:SCR_002798 FlowJo 10 BD Biosciences RRID:SCR_008520 SAS System software 9.4 SAS Institute Inc. RRID:SCR_008567 CTL Immunospot suite 2.7 Cellular Technology Limited RRID:SCR_011082 SPICE 6 NIH/NIAID https://niaid.github.io/spice/ RRID:SCR_016603 Article ll OPEN ACCESS .. Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, Stefania Capone (Stefania.capone@reithera.com).

    Enzyme-linked Immunospot:

    Article Title: GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial.
    Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Mouse anti human CD19 conjugated to APC-Vio770 (clone LT19) Miltenyi Biotec Cat# 130-113-166; RRID: AB_2725994 mouse anti human CD27 conjugated to Vio Bright FITC (clone M-T271) Miltenyi Biotec Cat# 130-113-634; RRID: AB_2751160 mouse anti human IgA conjugated to VioGreen (clone IS11-8E10) Miltenyi Biotec Cat# 130-113-481; RRID: AB_2734099 mouse anti human IgM conjugated to APC (clone Pj2-22H3) Miltenyi Biotec Cat# 130-122-915; RRID: AB_2801965 mouse anti human IgG conjugated to VioBlue (clone IS11-3B2.2.3) Miltenyi Biotec Cat# 130-119-881; RRID: AB_2751904 mouse anti human CD24 conjugated to BV711 (clone ML5) BD Biosciences Cat# 563401; RRID: AB_2631261 mouse anti human CD107a conjugated to PE-CF594 (clone H4A3) BD Biosciences Cat# 562628; RRID: AB_2737686 mouse anti human CD3 conjugated to BUV395 (clone UCHT1) BD Biosciences Cat# 563546; RRID: AB_2744387 mouse anti human CD4 conjugated to BUV737 clone SK3 BD Biosciences Cat# 612748; RRID: AB_2870079 mouse anti human CD8 conjugated to BV605 (clone SK1) BD Biosciences Cat# 564116; RRID: AB_2869551 mouse anti human CD154 conjugated to BB700 (clone TRAP1) BD Biosciences Cat# 745814; RRID: AB_2743265 mouse anti human IFNg conjugated to APC clone B27 BD Biosciences Cat# 554702; RRID: AB_398580 rat anti human IL-2 conjugated to PE (clone mQ1-17H12) BD Biosciences Cat# 559334; RRID: AB_397231 mouse anti human TNFa conjugated to BV650 (clone Mab11) BD Biosciences Cat# 563418; RRID: AB_2738194 mouse anti human CD69 conjugated to APC-R700 (clone FN50) BD Biosciences Cat# 565154; RRID: AB_2744449 Biological samples Human Serum Study Participants N/A Human PBMC Study Participants N/A Chemicals, peptides, and recombinant proteins PepMixTM SARS-CoV-2 (Spike Glycoprotein) JPT Cat# PM-WCPV-S-1 PepMixTM SARS-CoV-2 (Spike B.1.617.2/ Delta) JPT Cat# PM-SARS2-SMUT06-1 PepMixTM SARS-CoV-2 (Spike B.1.1.529/ BA.1/Omicron) JPT Cat# PM-SARS2-SMUT08-1 CEFX Ultra SuperStim Pool JPT Cat# PM-CEFX-1 Overlapping SARS-CoV-2 Spike 15mers custom ordered from Elabscience Biotech Inc (Lanini S. et al., SciTraslMed 2021) N/A, Staphylococcal enterotoxin B from Staphylococcus aureus Sigma-Aldrich Cat# S4881 GolgiPlug BD Biosciences Cat# 555029 (Continued on next page) e1 Cell Reports Medicine 4, 101084, June 20, 2023 .. REAGENT or RESOURCE SOURCE IDENTIFIER Brilliant Stain Buffer BD Biosciences Cat# 563794 BD Fixation/Permeabilization Kit BD Biosciences Cat# 554714 FVS780 BD Biosciences Cat# 565388 HyClone Defined FBS, US Origin, 500 mL Cytiva Cat# SH30070.03 CTL-WashTM Supplement 10x Immunospot Cat# CTLW-010 CellTrace Violet ThermoFisher Cat# C34571 Critical commercial assays COVID-SeroIndex, Kantaro Quantitative SARS-CoV-2 IgG Antibody Kit (Spike) R&D Systems Cat# DSR200 ARCHITECT SARS-CoV-2 IgG kit (Nucleocapsid) Abbot Cat# 6R86 ARCHITECT SARS-CoV-2 IgG II Quant (RBD) Abbot Cat# 6S60 Human IFN-g ELISpot plus kit Mabtech Cat# 3420-4APT IFNg-IL5 Fluorospot Mabtech Cat# FSP-0108 SARS-CoV-2 Spike B cell analysis kit Miltenyi Biotec Cat# 130-128-022 SARS-CoV-2 live neutralization assay Viroclinics Biosciences-Cerba N/A Pseudo-neutralization assay (D614 and D strains) Nexelis-Q2 solutions https://nexelis.com/our-expertise/ infectious-diseases/covid-19/ Pseudo-neutralization assay (D614) Monogram Biosciences-Labcorp https://monogrambio.labcorp.com/ phenosense-sars-cov-2neutralizing-antibody Software and algorithms Graphpad PRISM 7 GraphPad RRID:SCR_002798 FlowJo 10 BD Biosciences RRID:SCR_008520 SAS System software 9.4 SAS Institute Inc. RRID:SCR_008567 CTL Immunospot suite 2.7 Cellular Technology Limited RRID:SCR_011082 SPICE 6 NIH/NIAID https://niaid.github.io/spice/ RRID:SCR_016603 Article ll OPEN ACCESS .. Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, Stefania Capone (Stefania.capone@reithera.com).

    Neutralization:

    Article Title: GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial.
    Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Mouse anti human CD19 conjugated to APC-Vio770 (clone LT19) Miltenyi Biotec Cat# 130-113-166; RRID: AB_2725994 mouse anti human CD27 conjugated to Vio Bright FITC (clone M-T271) Miltenyi Biotec Cat# 130-113-634; RRID: AB_2751160 mouse anti human IgA conjugated to VioGreen (clone IS11-8E10) Miltenyi Biotec Cat# 130-113-481; RRID: AB_2734099 mouse anti human IgM conjugated to APC (clone Pj2-22H3) Miltenyi Biotec Cat# 130-122-915; RRID: AB_2801965 mouse anti human IgG conjugated to VioBlue (clone IS11-3B2.2.3) Miltenyi Biotec Cat# 130-119-881; RRID: AB_2751904 mouse anti human CD24 conjugated to BV711 (clone ML5) BD Biosciences Cat# 563401; RRID: AB_2631261 mouse anti human CD107a conjugated to PE-CF594 (clone H4A3) BD Biosciences Cat# 562628; RRID: AB_2737686 mouse anti human CD3 conjugated to BUV395 (clone UCHT1) BD Biosciences Cat# 563546; RRID: AB_2744387 mouse anti human CD4 conjugated to BUV737 clone SK3 BD Biosciences Cat# 612748; RRID: AB_2870079 mouse anti human CD8 conjugated to BV605 (clone SK1) BD Biosciences Cat# 564116; RRID: AB_2869551 mouse anti human CD154 conjugated to BB700 (clone TRAP1) BD Biosciences Cat# 745814; RRID: AB_2743265 mouse anti human IFNg conjugated to APC clone B27 BD Biosciences Cat# 554702; RRID: AB_398580 rat anti human IL-2 conjugated to PE (clone mQ1-17H12) BD Biosciences Cat# 559334; RRID: AB_397231 mouse anti human TNFa conjugated to BV650 (clone Mab11) BD Biosciences Cat# 563418; RRID: AB_2738194 mouse anti human CD69 conjugated to APC-R700 (clone FN50) BD Biosciences Cat# 565154; RRID: AB_2744449 Biological samples Human Serum Study Participants N/A Human PBMC Study Participants N/A Chemicals, peptides, and recombinant proteins PepMixTM SARS-CoV-2 (Spike Glycoprotein) JPT Cat# PM-WCPV-S-1 PepMixTM SARS-CoV-2 (Spike B.1.617.2/ Delta) JPT Cat# PM-SARS2-SMUT06-1 PepMixTM SARS-CoV-2 (Spike B.1.1.529/ BA.1/Omicron) JPT Cat# PM-SARS2-SMUT08-1 CEFX Ultra SuperStim Pool JPT Cat# PM-CEFX-1 Overlapping SARS-CoV-2 Spike 15mers custom ordered from Elabscience Biotech Inc (Lanini S. et al., SciTraslMed 2021) N/A, Staphylococcal enterotoxin B from Staphylococcus aureus Sigma-Aldrich Cat# S4881 GolgiPlug BD Biosciences Cat# 555029 (Continued on next page) e1 Cell Reports Medicine 4, 101084, June 20, 2023 .. REAGENT or RESOURCE SOURCE IDENTIFIER Brilliant Stain Buffer BD Biosciences Cat# 563794 BD Fixation/Permeabilization Kit BD Biosciences Cat# 554714 FVS780 BD Biosciences Cat# 565388 HyClone Defined FBS, US Origin, 500 mL Cytiva Cat# SH30070.03 CTL-WashTM Supplement 10x Immunospot Cat# CTLW-010 CellTrace Violet ThermoFisher Cat# C34571 Critical commercial assays COVID-SeroIndex, Kantaro Quantitative SARS-CoV-2 IgG Antibody Kit (Spike) R&D Systems Cat# DSR200 ARCHITECT SARS-CoV-2 IgG kit (Nucleocapsid) Abbot Cat# 6R86 ARCHITECT SARS-CoV-2 IgG II Quant (RBD) Abbot Cat# 6S60 Human IFN-g ELISpot plus kit Mabtech Cat# 3420-4APT IFNg-IL5 Fluorospot Mabtech Cat# FSP-0108 SARS-CoV-2 Spike B cell analysis kit Miltenyi Biotec Cat# 130-128-022 SARS-CoV-2 live neutralization assay Viroclinics Biosciences-Cerba N/A Pseudo-neutralization assay (D614 and D strains) Nexelis-Q2 solutions https://nexelis.com/our-expertise/ infectious-diseases/covid-19/ Pseudo-neutralization assay (D614) Monogram Biosciences-Labcorp https://monogrambio.labcorp.com/ phenosense-sars-cov-2neutralizing-antibody Software and algorithms Graphpad PRISM 7 GraphPad RRID:SCR_002798 FlowJo 10 BD Biosciences RRID:SCR_008520 SAS System software 9.4 SAS Institute Inc. RRID:SCR_008567 CTL Immunospot suite 2.7 Cellular Technology Limited RRID:SCR_011082 SPICE 6 NIH/NIAID https://niaid.github.io/spice/ RRID:SCR_016603 Article ll OPEN ACCESS .. Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, Stefania Capone (Stefania.capone@reithera.com).

    Software:

    Article Title: GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial.
    Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Mouse anti human CD19 conjugated to APC-Vio770 (clone LT19) Miltenyi Biotec Cat# 130-113-166; RRID: AB_2725994 mouse anti human CD27 conjugated to Vio Bright FITC (clone M-T271) Miltenyi Biotec Cat# 130-113-634; RRID: AB_2751160 mouse anti human IgA conjugated to VioGreen (clone IS11-8E10) Miltenyi Biotec Cat# 130-113-481; RRID: AB_2734099 mouse anti human IgM conjugated to APC (clone Pj2-22H3) Miltenyi Biotec Cat# 130-122-915; RRID: AB_2801965 mouse anti human IgG conjugated to VioBlue (clone IS11-3B2.2.3) Miltenyi Biotec Cat# 130-119-881; RRID: AB_2751904 mouse anti human CD24 conjugated to BV711 (clone ML5) BD Biosciences Cat# 563401; RRID: AB_2631261 mouse anti human CD107a conjugated to PE-CF594 (clone H4A3) BD Biosciences Cat# 562628; RRID: AB_2737686 mouse anti human CD3 conjugated to BUV395 (clone UCHT1) BD Biosciences Cat# 563546; RRID: AB_2744387 mouse anti human CD4 conjugated to BUV737 clone SK3 BD Biosciences Cat# 612748; RRID: AB_2870079 mouse anti human CD8 conjugated to BV605 (clone SK1) BD Biosciences Cat# 564116; RRID: AB_2869551 mouse anti human CD154 conjugated to BB700 (clone TRAP1) BD Biosciences Cat# 745814; RRID: AB_2743265 mouse anti human IFNg conjugated to APC clone B27 BD Biosciences Cat# 554702; RRID: AB_398580 rat anti human IL-2 conjugated to PE (clone mQ1-17H12) BD Biosciences Cat# 559334; RRID: AB_397231 mouse anti human TNFa conjugated to BV650 (clone Mab11) BD Biosciences Cat# 563418; RRID: AB_2738194 mouse anti human CD69 conjugated to APC-R700 (clone FN50) BD Biosciences Cat# 565154; RRID: AB_2744449 Biological samples Human Serum Study Participants N/A Human PBMC Study Participants N/A Chemicals, peptides, and recombinant proteins PepMixTM SARS-CoV-2 (Spike Glycoprotein) JPT Cat# PM-WCPV-S-1 PepMixTM SARS-CoV-2 (Spike B.1.617.2/ Delta) JPT Cat# PM-SARS2-SMUT06-1 PepMixTM SARS-CoV-2 (Spike B.1.1.529/ BA.1/Omicron) JPT Cat# PM-SARS2-SMUT08-1 CEFX Ultra SuperStim Pool JPT Cat# PM-CEFX-1 Overlapping SARS-CoV-2 Spike 15mers custom ordered from Elabscience Biotech Inc (Lanini S. et al., SciTraslMed 2021) N/A, Staphylococcal enterotoxin B from Staphylococcus aureus Sigma-Aldrich Cat# S4881 GolgiPlug BD Biosciences Cat# 555029 (Continued on next page) e1 Cell Reports Medicine 4, 101084, June 20, 2023 .. REAGENT or RESOURCE SOURCE IDENTIFIER Brilliant Stain Buffer BD Biosciences Cat# 563794 BD Fixation/Permeabilization Kit BD Biosciences Cat# 554714 FVS780 BD Biosciences Cat# 565388 HyClone Defined FBS, US Origin, 500 mL Cytiva Cat# SH30070.03 CTL-WashTM Supplement 10x Immunospot Cat# CTLW-010 CellTrace Violet ThermoFisher Cat# C34571 Critical commercial assays COVID-SeroIndex, Kantaro Quantitative SARS-CoV-2 IgG Antibody Kit (Spike) R&D Systems Cat# DSR200 ARCHITECT SARS-CoV-2 IgG kit (Nucleocapsid) Abbot Cat# 6R86 ARCHITECT SARS-CoV-2 IgG II Quant (RBD) Abbot Cat# 6S60 Human IFN-g ELISpot plus kit Mabtech Cat# 3420-4APT IFNg-IL5 Fluorospot Mabtech Cat# FSP-0108 SARS-CoV-2 Spike B cell analysis kit Miltenyi Biotec Cat# 130-128-022 SARS-CoV-2 live neutralization assay Viroclinics Biosciences-Cerba N/A Pseudo-neutralization assay (D614 and D strains) Nexelis-Q2 solutions https://nexelis.com/our-expertise/ infectious-diseases/covid-19/ Pseudo-neutralization assay (D614) Monogram Biosciences-Labcorp https://monogrambio.labcorp.com/ phenosense-sars-cov-2neutralizing-antibody Software and algorithms Graphpad PRISM 7 GraphPad RRID:SCR_002798 FlowJo 10 BD Biosciences RRID:SCR_008520 SAS System software 9.4 SAS Institute Inc. RRID:SCR_008567 CTL Immunospot suite 2.7 Cellular Technology Limited RRID:SCR_011082 SPICE 6 NIH/NIAID https://niaid.github.io/spice/ RRID:SCR_016603 Article ll OPEN ACCESS .. Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, Stefania Capone (Stefania.capone@reithera.com).



    Similar Products

    95
    Sino Biological sars-cov / sars-cov-2 nucleocapsid antibody, mouse mab
    Sars Cov / Sars Cov 2 Nucleocapsid Antibody, Mouse Mab, supplied by Sino Biological, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sars-cov/SARS-CoV+%2F+SARS-CoV-2+Nucleocapsid+Antibody%2C+Mouse+MAb/custom%4040143-mm08%4042476130
    Average 95 stars, based on 1 article reviews
    sars-cov / sars-cov-2 nucleocapsid antibody, mouse mab - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    94
    MedChemExpress sars cov 2 wa 1
    A Schematic <t>of</t> <t>the</t> <t>SARS-CoV-2</t> genome. Targets explicitly labeled and investigated in this study are indicated in black text, while uninvestigated regions are shown in gray. Red markers indicate the binding sites for the vgRNA FISH probes. B Model of a SARS-CoV-2–infected A549-ACE2 cell highlighting the structural evolution of viral replication organelles (ROs) and their previously reported intracellular localizations. Key cellular targets investigated in this study are indicated. C Membrane topology of the uncleaved viral polyproteins pp1a and pp1ab. The schematic illustrates the relative positions of the individual non-structural protein (NSP) domains with respect to the endoplasmic reticulum (ER) membrane following translation. Arrows indicate known proteolytic cleavage sites targeted by nsp3 (orange) and nsp5 (blue).
    Sars Cov 2 Wa 1, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sars-cov/SARS-CoV-2+S/pmc13487147-408-13-55
    Average 94 stars, based on 1 article reviews
    sars cov 2 wa 1 - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    86
    Roche roche s elecsys anti sars cov 2 assay
    A Schematic <t>of</t> <t>the</t> <t>SARS-CoV-2</t> genome. Targets explicitly labeled and investigated in this study are indicated in black text, while uninvestigated regions are shown in gray. Red markers indicate the binding sites for the vgRNA FISH probes. B Model of a SARS-CoV-2–infected A549-ACE2 cell highlighting the structural evolution of viral replication organelles (ROs) and their previously reported intracellular localizations. Key cellular targets investigated in this study are indicated. C Membrane topology of the uncleaved viral polyproteins pp1a and pp1ab. The schematic illustrates the relative positions of the individual non-structural protein (NSP) domains with respect to the endoplasmic reticulum (ER) membrane following translation. Arrows indicate known proteolytic cleavage sites targeted by nsp3 (orange) and nsp5 (blue).
    Roche S Elecsys Anti Sars Cov 2 Assay, supplied by Roche, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sars-cov/nct05582512-29-17-21
    Average 86 stars, based on 1 article reviews
    roche s elecsys anti sars cov 2 assay - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    97
    Miltenyi Biotec igm apc pj2 22h3 miltenyi
    A Schematic <t>of</t> <t>the</t> <t>SARS-CoV-2</t> genome. Targets explicitly labeled and investigated in this study are indicated in black text, while uninvestigated regions are shown in gray. Red markers indicate the binding sites for the vgRNA FISH probes. B Model of a SARS-CoV-2–infected A549-ACE2 cell highlighting the structural evolution of viral replication organelles (ROs) and their previously reported intracellular localizations. Key cellular targets investigated in this study are indicated. C Membrane topology of the uncleaved viral polyproteins pp1a and pp1ab. The schematic illustrates the relative positions of the individual non-structural protein (NSP) domains with respect to the endoplasmic reticulum (ER) membrane following translation. Arrows indicate known proteolytic cleavage sites targeted by nsp3 (orange) and nsp5 (blue).
    Igm Apc Pj2 22h3 Miltenyi, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sars-cov/SARS-CoV-2+Spike+B+Cell+Analysis+Kit%2C+anti-human/pm42389809-268-167-170
    Average 97 stars, based on 1 article reviews
    igm apc pj2 22h3 miltenyi - by Bioz Stars, 2026-09
    97/100 stars
      Buy from Supplier

    86
    Acon Biotech Hangzhou Co Ltd sars cov 2 nucleocapsid by immunochromatography
    A Schematic <t>of</t> <t>the</t> <t>SARS-CoV-2</t> genome. Targets explicitly labeled and investigated in this study are indicated in black text, while uninvestigated regions are shown in gray. Red markers indicate the binding sites for the vgRNA FISH probes. B Model of a SARS-CoV-2–infected A549-ACE2 cell highlighting the structural evolution of viral replication organelles (ROs) and their previously reported intracellular localizations. Key cellular targets investigated in this study are indicated. C Membrane topology of the uncleaved viral polyproteins pp1a and pp1ab. The schematic illustrates the relative positions of the individual non-structural protein (NSP) domains with respect to the endoplasmic reticulum (ER) membrane following translation. Arrows indicate known proteolytic cleavage sites targeted by nsp3 (orange) and nsp5 (blue).
    Sars Cov 2 Nucleocapsid By Immunochromatography, supplied by Acon Biotech Hangzhou Co Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sars-cov/pm42035785-87-10-14
    Average 86 stars, based on 1 article reviews
    sars cov 2 nucleocapsid by immunochromatography - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    86
    Biotechnology Information sars cov 2 proteins
    A Schematic <t>of</t> <t>the</t> <t>SARS-CoV-2</t> genome. Targets explicitly labeled and investigated in this study are indicated in black text, while uninvestigated regions are shown in gray. Red markers indicate the binding sites for the vgRNA FISH probes. B Model of a SARS-CoV-2–infected A549-ACE2 cell highlighting the structural evolution of viral replication organelles (ROs) and their previously reported intracellular localizations. Key cellular targets investigated in this study are indicated. C Membrane topology of the uncleaved viral polyproteins pp1a and pp1ab. The schematic illustrates the relative positions of the individual non-structural protein (NSP) domains with respect to the endoplasmic reticulum (ER) membrane following translation. Arrows indicate known proteolytic cleavage sites targeted by nsp3 (orange) and nsp5 (blue).
    Sars Cov 2 Proteins, supplied by Biotechnology Information, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sars-cov/1+2+cov+hu+sars+strain+wuhan/pm42281397-75-13-24
    Average 86 stars, based on 1 article reviews
    sars cov 2 proteins - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    86
    Haibo Inc plant produced sars cov 2 virus
    A Schematic <t>of</t> <t>the</t> <t>SARS-CoV-2</t> genome. Targets explicitly labeled and investigated in this study are indicated in black text, while uninvestigated regions are shown in gray. Red markers indicate the binding sites for the vgRNA FISH probes. B Model of a SARS-CoV-2–infected A549-ACE2 cell highlighting the structural evolution of viral replication organelles (ROs) and their previously reported intracellular localizations. Key cellular targets investigated in this study are indicated. C Membrane topology of the uncleaved viral polyproteins pp1a and pp1ab. The schematic illustrates the relative positions of the individual non-structural protein (NSP) domains with respect to the endoplasmic reticulum (ER) membrane following translation. Arrows indicate known proteolytic cleavage sites targeted by nsp3 (orange) and nsp5 (blue).
    Plant Produced Sars Cov 2 Virus, supplied by Haibo Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sars-cov/2+cov+like+particles+plant+produced+sars+virus/pm42288894-12-5-46
    Average 86 stars, based on 1 article reviews
    plant produced sars cov 2 virus - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    86
    Sanofi sars cov 2 vaccine strain selection
    A Schematic <t>of</t> <t>the</t> <t>SARS-CoV-2</t> genome. Targets explicitly labeled and investigated in this study are indicated in black text, while uninvestigated regions are shown in gray. Red markers indicate the binding sites for the vgRNA FISH probes. B Model of a SARS-CoV-2–infected A549-ACE2 cell highlighting the structural evolution of viral replication organelles (ROs) and their previously reported intracellular localizations. Key cellular targets investigated in this study are indicated. C Membrane topology of the uncleaved viral polyproteins pp1a and pp1ab. The schematic illustrates the relative positions of the individual non-structural protein (NSP) domains with respect to the endoplasmic reticulum (ER) membrane following translation. Arrows indicate known proteolytic cleavage sites targeted by nsp3 (orange) and nsp5 (blue).
    Sars Cov 2 Vaccine Strain Selection, supplied by Sanofi, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sars-cov/2+cov+sars+selection+strain+vaccine/pm42284681-190-24-22
    Average 86 stars, based on 1 article reviews
    sars cov 2 vaccine strain selection - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    86
    Altona Diagnostics realstar sars cov 2 rt pcr kit 1 0
    A Schematic <t>of</t> <t>the</t> <t>SARS-CoV-2</t> genome. Targets explicitly labeled and investigated in this study are indicated in black text, while uninvestigated regions are shown in gray. Red markers indicate the binding sites for the vgRNA FISH probes. B Model of a SARS-CoV-2–infected A549-ACE2 cell highlighting the structural evolution of viral replication organelles (ROs) and their previously reported intracellular localizations. Key cellular targets investigated in this study are indicated. C Membrane topology of the uncleaved viral polyproteins pp1a and pp1ab. The schematic illustrates the relative positions of the individual non-structural protein (NSP) domains with respect to the endoplasmic reticulum (ER) membrane following translation. Arrows indicate known proteolytic cleavage sites targeted by nsp3 (orange) and nsp5 (blue).
    Realstar Sars Cov 2 Rt Pcr Kit 1 0, supplied by Altona Diagnostics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sars-cov/2+cov+kit+pcr+realstar+rt+sars/pm42283351-65-8-16
    Average 86 stars, based on 1 article reviews
    realstar sars cov 2 rt pcr kit 1 0 - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    86
    Abbott Laboratories sars cov 2 igg ii quant assay
    A Schematic <t>of</t> <t>the</t> <t>SARS-CoV-2</t> genome. Targets explicitly labeled and investigated in this study are indicated in black text, while uninvestigated regions are shown in gray. Red markers indicate the binding sites for the vgRNA FISH probes. B Model of a SARS-CoV-2–infected A549-ACE2 cell highlighting the structural evolution of viral replication organelles (ROs) and their previously reported intracellular localizations. Key cellular targets investigated in this study are indicated. C Membrane topology of the uncleaved viral polyproteins pp1a and pp1ab. The schematic illustrates the relative positions of the individual non-structural protein (NSP) domains with respect to the endoplasmic reticulum (ER) membrane following translation. Arrows indicate known proteolytic cleavage sites targeted by nsp3 (orange) and nsp5 (blue).
    Sars Cov 2 Igg Ii Quant Assay, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sars-cov/2+anti+assay+cov+igg+ii+quant+sars/pm42279051-43-10-15
    Average 86 stars, based on 1 article reviews
    sars cov 2 igg ii quant assay - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    Image Search Results


    A Schematic of the SARS-CoV-2 genome. Targets explicitly labeled and investigated in this study are indicated in black text, while uninvestigated regions are shown in gray. Red markers indicate the binding sites for the vgRNA FISH probes. B Model of a SARS-CoV-2–infected A549-ACE2 cell highlighting the structural evolution of viral replication organelles (ROs) and their previously reported intracellular localizations. Key cellular targets investigated in this study are indicated. C Membrane topology of the uncleaved viral polyproteins pp1a and pp1ab. The schematic illustrates the relative positions of the individual non-structural protein (NSP) domains with respect to the endoplasmic reticulum (ER) membrane following translation. Arrows indicate known proteolytic cleavage sites targeted by nsp3 (orange) and nsp5 (blue).

    Journal: Nature Communications

    Article Title: Super-resolution atlas of SARS-CoV-2 infection reveals protease-dependent organelle maturation, dsRNA landscapes, and intracellular structural proteins

    doi: 10.1038/s41467-026-75289-x

    Figure Lengend Snippet: A Schematic of the SARS-CoV-2 genome. Targets explicitly labeled and investigated in this study are indicated in black text, while uninvestigated regions are shown in gray. Red markers indicate the binding sites for the vgRNA FISH probes. B Model of a SARS-CoV-2–infected A549-ACE2 cell highlighting the structural evolution of viral replication organelles (ROs) and their previously reported intracellular localizations. Key cellular targets investigated in this study are indicated. C Membrane topology of the uncleaved viral polyproteins pp1a and pp1ab. The schematic illustrates the relative positions of the individual non-structural protein (NSP) domains with respect to the endoplasmic reticulum (ER) membrane following translation. Arrows indicate known proteolytic cleavage sites targeted by nsp3 (orange) and nsp5 (blue).

    Article Snippet: For nirmatrelvir washout experiments, cells were washed once with PBS and incubated with SARS-CoV-2 WA 1 (USA-WA1/2020) at an MOI of 10 in 50 μL of DMEM containing 2% FBS for 6 h. The viral inoculum was then removed, and cells were cultured in 100 μL of DMEM containing 2% FBS and 288 nM nirmatrelvir (MedChemExpress, HY-138687) for 18 h. A subset of cells was then washed with PBS and fixed by 4% PFA and 0.1% glutaraldehyde in PBS for 1 h. The remaining cells were washed and cultured in fresh DMEM containing 2% FBS for an additional 24 h before being washed and fixed as described above.

    Techniques: Labeling, Binding Assay, Infection, Membrane

    A Representative three-color SR image of a SARS-CoV-2–infected A549-ACE2 cell at an early infection stage, labeled for nsp1 (yellow), nsp4 (magenta) and dsRNA (cyan). Nsp1 localizes diffusely throughout the cytoplasm, while nsp4 encapsulates round dsRNA clusters (double-membrane vesicles, DMVs). B Representative two-color SR image of nsp1 (yellow) and 18S ribosomal RNA (rRNA) (magenta) indicates diffused localization of both targets within the same regions of the cytoplasm. Inset: pair-correlation functions between nsp1 and 18S localizations peak at r = 0 nm, suggesting an association between nsp1 and 18S rRNA. The blue dashed line approximates the position of a nucleolus, characterized by an increased density of 18S rRNA. C Representative SR image of an infected cell at an early infection stage, labeled for nsp2 (magenta), nsp3 (yellow) and dsRNA (cyan). Nsp2 and nsp3 co-encapsulate dsRNA clusters (DMVs) and localize between accumulations of DMVs (putative convoluted membranes, CMs). D In late infection, a significant portion of cellular nsp2 (magenta) localizes to fragmented and dispersed Golgi bodies (labeled with an anti-Giantin antibody, green). Bottom panels (1–3) display magnified views of selected Golgi bodies; yellow arrowheads indicate additional examples of Golgi bodies within the large image. E SR image of a cell in early infection suggests localization of nsp5 (magenta) within DMVs, as indicated by nsp3 (yellow, DMV membrane) and dsRNA (cyan, DMV core). F SR image of a cell at a late infection stage indicates that nsp5 (magenta) localizes to vgRNA-labeled (green) DMVs. Inset: pair-correlation functions between nsp5 and vgRNA localizations in late infection peak at r = 0 nm, indicating a strong correlation between these two targets. In the pair-correlation function plots in ( B ) and ( F ), faint blue lines represent individual cells, faint red lines represent g 12 (r) calculated assuming the complete spatial randomness (CSR), and bold lines represent the mean values across all analyzed cells. Color-framed boxes indicate magnified regions shown in the corresponding panels below. White dashed curves denote the approximate nuclear edge. White arrowheads in ( A ), ( C ), ( E ) indicate selected individual DMVs, whereas green arrowheads point to examples of DMV aggregates associated with nsp3-labeled CMs. Scale bars: 2 µm (large images), 500 nm (magnified images in ( C ), ( D )), and 200 nm (magnified images in ( E ), ( F )).

    Journal: Nature Communications

    Article Title: Super-resolution atlas of SARS-CoV-2 infection reveals protease-dependent organelle maturation, dsRNA landscapes, and intracellular structural proteins

    doi: 10.1038/s41467-026-75289-x

    Figure Lengend Snippet: A Representative three-color SR image of a SARS-CoV-2–infected A549-ACE2 cell at an early infection stage, labeled for nsp1 (yellow), nsp4 (magenta) and dsRNA (cyan). Nsp1 localizes diffusely throughout the cytoplasm, while nsp4 encapsulates round dsRNA clusters (double-membrane vesicles, DMVs). B Representative two-color SR image of nsp1 (yellow) and 18S ribosomal RNA (rRNA) (magenta) indicates diffused localization of both targets within the same regions of the cytoplasm. Inset: pair-correlation functions between nsp1 and 18S localizations peak at r = 0 nm, suggesting an association between nsp1 and 18S rRNA. The blue dashed line approximates the position of a nucleolus, characterized by an increased density of 18S rRNA. C Representative SR image of an infected cell at an early infection stage, labeled for nsp2 (magenta), nsp3 (yellow) and dsRNA (cyan). Nsp2 and nsp3 co-encapsulate dsRNA clusters (DMVs) and localize between accumulations of DMVs (putative convoluted membranes, CMs). D In late infection, a significant portion of cellular nsp2 (magenta) localizes to fragmented and dispersed Golgi bodies (labeled with an anti-Giantin antibody, green). Bottom panels (1–3) display magnified views of selected Golgi bodies; yellow arrowheads indicate additional examples of Golgi bodies within the large image. E SR image of a cell in early infection suggests localization of nsp5 (magenta) within DMVs, as indicated by nsp3 (yellow, DMV membrane) and dsRNA (cyan, DMV core). F SR image of a cell at a late infection stage indicates that nsp5 (magenta) localizes to vgRNA-labeled (green) DMVs. Inset: pair-correlation functions between nsp5 and vgRNA localizations in late infection peak at r = 0 nm, indicating a strong correlation between these two targets. In the pair-correlation function plots in ( B ) and ( F ), faint blue lines represent individual cells, faint red lines represent g 12 (r) calculated assuming the complete spatial randomness (CSR), and bold lines represent the mean values across all analyzed cells. Color-framed boxes indicate magnified regions shown in the corresponding panels below. White dashed curves denote the approximate nuclear edge. White arrowheads in ( A ), ( C ), ( E ) indicate selected individual DMVs, whereas green arrowheads point to examples of DMV aggregates associated with nsp3-labeled CMs. Scale bars: 2 µm (large images), 500 nm (magnified images in ( C ), ( D )), and 200 nm (magnified images in ( E ), ( F )).

    Article Snippet: For nirmatrelvir washout experiments, cells were washed once with PBS and incubated with SARS-CoV-2 WA 1 (USA-WA1/2020) at an MOI of 10 in 50 μL of DMEM containing 2% FBS for 6 h. The viral inoculum was then removed, and cells were cultured in 100 μL of DMEM containing 2% FBS and 288 nM nirmatrelvir (MedChemExpress, HY-138687) for 18 h. A subset of cells was then washed with PBS and fixed by 4% PFA and 0.1% glutaraldehyde in PBS for 1 h. The remaining cells were washed and cultured in fresh DMEM containing 2% FBS for an additional 24 h before being washed and fixed as described above.

    Techniques: Infection, Labeling, Membrane

    A Schematic of a SARS-CoV-2 DMV with dsRNA in the center and nsp4 with nsp3 at the membrane pores. The positions of all remaining components were determined with respect to the known positions of these reference targets. B Representative three-color SR image of the cytoplasm of a typical A549-ACE2 cell at an early infection stage. DMVs (dashed circles) appear as round dsRNA clusters (cyan) surrounded by nsp4 (yellow) and nsp3 (red). A magnified view of a single DMV (white box, top right) reveals the three-layer organization of dsRNA, nsp4, and nsp3. The corresponding radial density distribution functions, g ( r ) (top rightmost plot), and rotationally averaged images (bottom right) display the three-layer structure averaged across n DMVs from 16 different cells. Representative three-color SR images of individual DMVs, corresponding radial density distribution functions, g ( r ), and rotationally averaged images for vgRNA, 18S rRNA, nsp1, nsp2, nsp5 and nsp9 relative to nsp4 and dsRNA. Data were obtained from 10 ( C ), 15 ( D ), 26 ( E ), 13 ( F ), 25 ( G ), and 22 ( H ) individual early-stage infected cells. Where applicable in ( B – H ), the average peak positions, R , of g ( r ), are indicated above the plots as the mean ± 95% CI, obtained via Gaussian fitting of the peak portion of g ( r ) following resampling with replacement (bootstrapping). n represents the total number of analyzed DMVs for each labeling combination. I Mean positions ± 95% CI for all NSPs associated with DMVs, calculated after rescaling the nsp4 positions within individual target groups ( B – H ) to match the global mean position of nsp4. The global position of nsp4 ± 95% CI (yellow error bar) was calculated across 13 groups ( B , F–H ) comprising n = 36,662 DMVs. Detailed data for the remaining NSPs are provided in Supplementary Fig. . J Angular bivariate pair-correlation functions, p ( θ ), of nsp4 with the indicated targets, represented as mean ± 95% CI. All targets peak at θ = 0, except 18S rRNA and nsp1. K Model of a mature, early-stage DMV based on the SR data. Scale bars: 1 µm ( B , overview image), 100 nm ( C – H , K and magnified individual DMVs and rotational averages in B ).

    Journal: Nature Communications

    Article Title: Super-resolution atlas of SARS-CoV-2 infection reveals protease-dependent organelle maturation, dsRNA landscapes, and intracellular structural proteins

    doi: 10.1038/s41467-026-75289-x

    Figure Lengend Snippet: A Schematic of a SARS-CoV-2 DMV with dsRNA in the center and nsp4 with nsp3 at the membrane pores. The positions of all remaining components were determined with respect to the known positions of these reference targets. B Representative three-color SR image of the cytoplasm of a typical A549-ACE2 cell at an early infection stage. DMVs (dashed circles) appear as round dsRNA clusters (cyan) surrounded by nsp4 (yellow) and nsp3 (red). A magnified view of a single DMV (white box, top right) reveals the three-layer organization of dsRNA, nsp4, and nsp3. The corresponding radial density distribution functions, g ( r ) (top rightmost plot), and rotationally averaged images (bottom right) display the three-layer structure averaged across n DMVs from 16 different cells. Representative three-color SR images of individual DMVs, corresponding radial density distribution functions, g ( r ), and rotationally averaged images for vgRNA, 18S rRNA, nsp1, nsp2, nsp5 and nsp9 relative to nsp4 and dsRNA. Data were obtained from 10 ( C ), 15 ( D ), 26 ( E ), 13 ( F ), 25 ( G ), and 22 ( H ) individual early-stage infected cells. Where applicable in ( B – H ), the average peak positions, R , of g ( r ), are indicated above the plots as the mean ± 95% CI, obtained via Gaussian fitting of the peak portion of g ( r ) following resampling with replacement (bootstrapping). n represents the total number of analyzed DMVs for each labeling combination. I Mean positions ± 95% CI for all NSPs associated with DMVs, calculated after rescaling the nsp4 positions within individual target groups ( B – H ) to match the global mean position of nsp4. The global position of nsp4 ± 95% CI (yellow error bar) was calculated across 13 groups ( B , F–H ) comprising n = 36,662 DMVs. Detailed data for the remaining NSPs are provided in Supplementary Fig. . J Angular bivariate pair-correlation functions, p ( θ ), of nsp4 with the indicated targets, represented as mean ± 95% CI. All targets peak at θ = 0, except 18S rRNA and nsp1. K Model of a mature, early-stage DMV based on the SR data. Scale bars: 1 µm ( B , overview image), 100 nm ( C – H , K and magnified individual DMVs and rotational averages in B ).

    Article Snippet: For nirmatrelvir washout experiments, cells were washed once with PBS and incubated with SARS-CoV-2 WA 1 (USA-WA1/2020) at an MOI of 10 in 50 μL of DMEM containing 2% FBS for 6 h. The viral inoculum was then removed, and cells were cultured in 100 μL of DMEM containing 2% FBS and 288 nM nirmatrelvir (MedChemExpress, HY-138687) for 18 h. A subset of cells was then washed with PBS and fixed by 4% PFA and 0.1% glutaraldehyde in PBS for 1 h. The remaining cells were washed and cultured in fresh DMEM containing 2% FBS for an additional 24 h before being washed and fixed as described above.

    Techniques: Membrane, Infection, Labeling

    Representative 3D dSTORM images of DMVs acquired using a double-helix point spread function (DHPSF), colabeled for dsRNA and nsp5 ( A ), nsp8 ( B ), or nsp10 ( C ) in SARS-CoV-2–infected A549-ACE2 cells. Each blue-framed set displays the same DMVs from different viewing angles. Axes are indicated in the corner of each panel (red, X; green, Y; blue, Z). D , E 3D-DHPSF imaging of dsRNA in an infected cell. The magnified view in ( E ) corresponds to the pink box in ( D ). The axial (Z) position of the fluorophores is color-coded according to the provided scale, where 0 µm represents the coverslip. F 2D dSTORM images of dsRNA colabeled with nsp4 reveal thin dsRNA connectors between larger dsRNA structures. These images correspond to the yellow boxes in the whole-cell image shown in Supplementary Fig. . G Examples of a cell in an early infection stage that contains large, approximately round dsRNA granules decorated with nsp9 puncta but lacking an nsp4 shell. The magnified panels on the right correspond to the green box in the large image. Green arrowheads highlight additional examples of dsRNA connectors, and white arrowheads indicate selected dsRNA granules lacking nsp4. Examples of large dsRNA granules largely lacking nsp4 but decorated with nsp5 ( H ), nsp13 ( I ), and nsp8 ( J ). White dashed curves denote the approximate nuclear edge. Scale bars: 5 µm (whole-cell images in D , G ), 500 nm ( H – J , and magnified panels in G ), and 200 nm ( A – C , E , F ).

    Journal: Nature Communications

    Article Title: Super-resolution atlas of SARS-CoV-2 infection reveals protease-dependent organelle maturation, dsRNA landscapes, and intracellular structural proteins

    doi: 10.1038/s41467-026-75289-x

    Figure Lengend Snippet: Representative 3D dSTORM images of DMVs acquired using a double-helix point spread function (DHPSF), colabeled for dsRNA and nsp5 ( A ), nsp8 ( B ), or nsp10 ( C ) in SARS-CoV-2–infected A549-ACE2 cells. Each blue-framed set displays the same DMVs from different viewing angles. Axes are indicated in the corner of each panel (red, X; green, Y; blue, Z). D , E 3D-DHPSF imaging of dsRNA in an infected cell. The magnified view in ( E ) corresponds to the pink box in ( D ). The axial (Z) position of the fluorophores is color-coded according to the provided scale, where 0 µm represents the coverslip. F 2D dSTORM images of dsRNA colabeled with nsp4 reveal thin dsRNA connectors between larger dsRNA structures. These images correspond to the yellow boxes in the whole-cell image shown in Supplementary Fig. . G Examples of a cell in an early infection stage that contains large, approximately round dsRNA granules decorated with nsp9 puncta but lacking an nsp4 shell. The magnified panels on the right correspond to the green box in the large image. Green arrowheads highlight additional examples of dsRNA connectors, and white arrowheads indicate selected dsRNA granules lacking nsp4. Examples of large dsRNA granules largely lacking nsp4 but decorated with nsp5 ( H ), nsp13 ( I ), and nsp8 ( J ). White dashed curves denote the approximate nuclear edge. Scale bars: 5 µm (whole-cell images in D , G ), 500 nm ( H – J , and magnified panels in G ), and 200 nm ( A – C , E , F ).

    Article Snippet: For nirmatrelvir washout experiments, cells were washed once with PBS and incubated with SARS-CoV-2 WA 1 (USA-WA1/2020) at an MOI of 10 in 50 μL of DMEM containing 2% FBS for 6 h. The viral inoculum was then removed, and cells were cultured in 100 μL of DMEM containing 2% FBS and 288 nM nirmatrelvir (MedChemExpress, HY-138687) for 18 h. A subset of cells was then washed with PBS and fixed by 4% PFA and 0.1% glutaraldehyde in PBS for 1 h. The remaining cells were washed and cultured in fresh DMEM containing 2% FBS for an additional 24 h before being washed and fixed as described above.

    Techniques: Infection, Imaging

    A Representative SR image of the M protein reveals distinct morphological structures. Magnified panels on the right correspond to the blue, green, and red boxes in the main image. B Representative SR image of the M protein shows virions arrayed on the cell membrane. Insets (yellow boxes) display magnified individual virions. C Representative two-color SR image of M protein (magenta) and the Golgi marker Giantin (green) indicates that M protein localizes within the Golgi apparatus. Bottom panels show magnified views of the region enclosed by the yellow box. D Representative two-color SR image of M protein (magenta) and the lysosomal marker LAMP1 (green) details the distribution of M protein inside and outside lysosomes. Panels on the right show magnified views of the regions enclosed by the corresponding colored boxes. E Representative two-color SR images demonstrate that M protein (magenta) codistributes with S1 protein (green) in both hollow (top) and solid (bottom) clusters. F Histogram of the equivalent radius of solid (blue, n = 276 clusters) and hollow (red, n = 180 clusters) M protein structures reveals two distinct size populations. Data were obtained from 22 cells and 8 independent experiments. G Representative two-color SR image of vgRNA (magenta) and N protein (green) at 24 hpi demonstrates colocalization exclusively in the cytoplasm outside ROs. Panels on the right show magnified views of the regions enclosed by the yellow and blue boxes. H Bivariate pair-correlation functions, g 12 ( r ), calculated between vgRNA and N protein localizations in the cytoplasm outside ROs indicate their close spatial association. I Representative two-color SR image of vgRNA (magenta) and S2 protein (green) shows a lack of colocalization both within and outside ROs. Panels on the right show magnified views of the regions enclosed by the corresponding colored boxes. J Bivariate pair-correlation functions, g 12 ( r ), calculated between vgRNA and S2 protein localizations in the cytoplasm outside ROs indicate a nanoscale spatial anti-correlation between them. White dashed lines in A , C , D , G , and I denote the approximate edge of the cell nucleus (large dark region). Color bars in A , B , D , E indicate the number of single-molecule localizations per SR pixel (20 × 20 nm 2 , except for B , 16 × 16 nm 2 ). Scale bars: 10 µm (large image in A ), 5 µm (large images in B – D , G , I ), 1 µm (magnified images in A, C), and 500 nm ( E and magnified images in D , G , I ). Images and data in A – F were obtained from SARS-CoV-2–infected A549-ACE2 cells, whereas those in G – J were obtained from infected Vero E6 cells. All cells were fixed at 24 hpi.

    Journal: Nature Communications

    Article Title: Super-resolution atlas of SARS-CoV-2 infection reveals protease-dependent organelle maturation, dsRNA landscapes, and intracellular structural proteins

    doi: 10.1038/s41467-026-75289-x

    Figure Lengend Snippet: A Representative SR image of the M protein reveals distinct morphological structures. Magnified panels on the right correspond to the blue, green, and red boxes in the main image. B Representative SR image of the M protein shows virions arrayed on the cell membrane. Insets (yellow boxes) display magnified individual virions. C Representative two-color SR image of M protein (magenta) and the Golgi marker Giantin (green) indicates that M protein localizes within the Golgi apparatus. Bottom panels show magnified views of the region enclosed by the yellow box. D Representative two-color SR image of M protein (magenta) and the lysosomal marker LAMP1 (green) details the distribution of M protein inside and outside lysosomes. Panels on the right show magnified views of the regions enclosed by the corresponding colored boxes. E Representative two-color SR images demonstrate that M protein (magenta) codistributes with S1 protein (green) in both hollow (top) and solid (bottom) clusters. F Histogram of the equivalent radius of solid (blue, n = 276 clusters) and hollow (red, n = 180 clusters) M protein structures reveals two distinct size populations. Data were obtained from 22 cells and 8 independent experiments. G Representative two-color SR image of vgRNA (magenta) and N protein (green) at 24 hpi demonstrates colocalization exclusively in the cytoplasm outside ROs. Panels on the right show magnified views of the regions enclosed by the yellow and blue boxes. H Bivariate pair-correlation functions, g 12 ( r ), calculated between vgRNA and N protein localizations in the cytoplasm outside ROs indicate their close spatial association. I Representative two-color SR image of vgRNA (magenta) and S2 protein (green) shows a lack of colocalization both within and outside ROs. Panels on the right show magnified views of the regions enclosed by the corresponding colored boxes. J Bivariate pair-correlation functions, g 12 ( r ), calculated between vgRNA and S2 protein localizations in the cytoplasm outside ROs indicate a nanoscale spatial anti-correlation between them. White dashed lines in A , C , D , G , and I denote the approximate edge of the cell nucleus (large dark region). Color bars in A , B , D , E indicate the number of single-molecule localizations per SR pixel (20 × 20 nm 2 , except for B , 16 × 16 nm 2 ). Scale bars: 10 µm (large image in A ), 5 µm (large images in B – D , G , I ), 1 µm (magnified images in A, C), and 500 nm ( E and magnified images in D , G , I ). Images and data in A – F were obtained from SARS-CoV-2–infected A549-ACE2 cells, whereas those in G – J were obtained from infected Vero E6 cells. All cells were fixed at 24 hpi.

    Article Snippet: For nirmatrelvir washout experiments, cells were washed once with PBS and incubated with SARS-CoV-2 WA 1 (USA-WA1/2020) at an MOI of 10 in 50 μL of DMEM containing 2% FBS for 6 h. The viral inoculum was then removed, and cells were cultured in 100 μL of DMEM containing 2% FBS and 288 nM nirmatrelvir (MedChemExpress, HY-138687) for 18 h. A subset of cells was then washed with PBS and fixed by 4% PFA and 0.1% glutaraldehyde in PBS for 1 h. The remaining cells were washed and cultured in fresh DMEM containing 2% FBS for an additional 24 h before being washed and fixed as described above.

    Techniques: Membrane, Marker, Infection

    A Representative SR image of an infected cell (MOI = 2) treated with 144 nM nirmatrelvir from 0 to 24 hpi and fixed at 24 hpi. Two regions with large multilayered bodies (MLBs) are magnified in the central panels. Density profiles (right, panels 1 and 2) show the localization density of nsp4 and nsp5 calculated perpendicular to the corresponding numbered white curves, in the direction indicated by the arrows (localization density orthogonal to the arrows was averaged). Both nsp4 and nsp5 localize in layered structures with a periodicity of ∼75 nm. SR images of infected cells (MOI = 10) treated with 288 nM nirmatrelvir from 6 to 24 hpi and fixed at 24 hpi. Nsp10 ( B ), nsp16 ( C ) and nsp3 ( D ) localize to the same multilayered structures as nsp5. E Magnified view of the region in ( D ) demonstrates the localization of nsp3 on both sides of nsp5-labeled layers. The averaged density profiles of nsp3 and nsp5 (right), calculated perpendicular to the numbered white curves in the direction of the arrows, reveal a double structure of nsp3 layers centered on single nsp5 layers. F , G Additional examples of MLBs from different cells in the same sample group, exhibiting this double nsp3 layer structure. H Confocal images of infected cells (MOI = 10) treated with 288 nM nirmatrelvir from 6 to 24 hpi and fixed at either 24 hpi (left) or 48 hpi (right), utilizing lysosome-associated membrane protein 1 (LAMP1, green) as a general cellular marker. In the left panel, only 6 cells in the bottom right corner display a weak punctate nsp5 signal (magenta) typical for an early infection phenotype, whereas the remaining cells show only LAMP1 signal and no detectable nsp5. In the right panel, nearly all cells exhibit a strong perinuclear nsp5 signal consistent with late-stage infection. I , J SR images of infected cells (MOI = 10) treated with 288 nM nirmatrelvir from 6 to 24 hpi and fixed at 48 hpi. A typical cell under these conditions displays a late-infection phenotype with highly dense perinuclear NSP and dsRNA localizations ( I ), whereas another typical cell shows prominent cytoplasmic MLBs ( J ). Among 32 infected cells imaged in SR at 48 hpi, 16 (50%) contained MLBs. In contrast, among 41 similarly treated infected cells fixed at 24 hpi (examples shown in B–G), 29 (∼71%) contained MLBs. White dashed curves denote the approximate nuclear edge. Scale bars: 50 µm ( H ), 5 µm (large images in A ; D , I , J ), 1 µm (middle panels in A ; B , C ), and 500 nm ( E – G ). All images and data were obtained from SARS-CoV-2–infected A549-ACE2 cells.

    Journal: Nature Communications

    Article Title: Super-resolution atlas of SARS-CoV-2 infection reveals protease-dependent organelle maturation, dsRNA landscapes, and intracellular structural proteins

    doi: 10.1038/s41467-026-75289-x

    Figure Lengend Snippet: A Representative SR image of an infected cell (MOI = 2) treated with 144 nM nirmatrelvir from 0 to 24 hpi and fixed at 24 hpi. Two regions with large multilayered bodies (MLBs) are magnified in the central panels. Density profiles (right, panels 1 and 2) show the localization density of nsp4 and nsp5 calculated perpendicular to the corresponding numbered white curves, in the direction indicated by the arrows (localization density orthogonal to the arrows was averaged). Both nsp4 and nsp5 localize in layered structures with a periodicity of ∼75 nm. SR images of infected cells (MOI = 10) treated with 288 nM nirmatrelvir from 6 to 24 hpi and fixed at 24 hpi. Nsp10 ( B ), nsp16 ( C ) and nsp3 ( D ) localize to the same multilayered structures as nsp5. E Magnified view of the region in ( D ) demonstrates the localization of nsp3 on both sides of nsp5-labeled layers. The averaged density profiles of nsp3 and nsp5 (right), calculated perpendicular to the numbered white curves in the direction of the arrows, reveal a double structure of nsp3 layers centered on single nsp5 layers. F , G Additional examples of MLBs from different cells in the same sample group, exhibiting this double nsp3 layer structure. H Confocal images of infected cells (MOI = 10) treated with 288 nM nirmatrelvir from 6 to 24 hpi and fixed at either 24 hpi (left) or 48 hpi (right), utilizing lysosome-associated membrane protein 1 (LAMP1, green) as a general cellular marker. In the left panel, only 6 cells in the bottom right corner display a weak punctate nsp5 signal (magenta) typical for an early infection phenotype, whereas the remaining cells show only LAMP1 signal and no detectable nsp5. In the right panel, nearly all cells exhibit a strong perinuclear nsp5 signal consistent with late-stage infection. I , J SR images of infected cells (MOI = 10) treated with 288 nM nirmatrelvir from 6 to 24 hpi and fixed at 48 hpi. A typical cell under these conditions displays a late-infection phenotype with highly dense perinuclear NSP and dsRNA localizations ( I ), whereas another typical cell shows prominent cytoplasmic MLBs ( J ). Among 32 infected cells imaged in SR at 48 hpi, 16 (50%) contained MLBs. In contrast, among 41 similarly treated infected cells fixed at 24 hpi (examples shown in B–G), 29 (∼71%) contained MLBs. White dashed curves denote the approximate nuclear edge. Scale bars: 50 µm ( H ), 5 µm (large images in A ; D , I , J ), 1 µm (middle panels in A ; B , C ), and 500 nm ( E – G ). All images and data were obtained from SARS-CoV-2–infected A549-ACE2 cells.

    Article Snippet: For nirmatrelvir washout experiments, cells were washed once with PBS and incubated with SARS-CoV-2 WA 1 (USA-WA1/2020) at an MOI of 10 in 50 μL of DMEM containing 2% FBS for 6 h. The viral inoculum was then removed, and cells were cultured in 100 μL of DMEM containing 2% FBS and 288 nM nirmatrelvir (MedChemExpress, HY-138687) for 18 h. A subset of cells was then washed with PBS and fixed by 4% PFA and 0.1% glutaraldehyde in PBS for 1 h. The remaining cells were washed and cultured in fresh DMEM containing 2% FBS for an additional 24 h before being washed and fixed as described above.

    Techniques: Infection, Labeling, Membrane, Marker